In biology, high AFP level is closely related to the activation of Fibroblast growth factor receptor (FGFR) pathway (28), and TKI drugs can effectively block FGFR and VEGFR signaling pathways, thereby inhibiting tumor angiogenesis, improving tumor perfusion, and enhancing follow-up treatment response (29–31). Here, AFP is linked to neoplasm.